 NEW YORK, May 16, 2022 GLOBE NEWSWIRE -- GBS Inc. Nasdaq: GBS, a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that, today announced that Dr. Steven Boyages, GBS interim CEO and Chairman of the Board, along with other management team members will participate at the H.C. Wainwright Global Investment Conference being held May 2326, 2022 and invites investors to participate via virtual one-on-one meetings. Please see additional details below: 